a public good project by the
Synthesis
Company
of California

© 2026

Célio Lopes Silva | doi.page

0 works0 citations0 h-index

Célio Lopes Silva

Universidade de Ribeirão Preto(BR)Universidade de São Paulo(BR)UNIFAVIP(BR)Clinics Hospital of Ribeirão Preto(BR)

Publications by Year

Research Areas

Tuberculosis Research and Epidemiology, Fungal Infections and Studies, Hepatitis B Virus Studies, Immunotherapy and Immune Responses, Mycobacterium research and diagnosis

Most-Cited Works

→ Therapy of tuberculosis in mice by DNA vaccination(1999)480 cited
→ II Consenso Brasileiro de Tuberculose: Diretrizes Brasileiras para Tuberculose 2004(2004)174 cited
→ Identification and Characterization of Protective T Cells in hsp65 DNA-Vaccinated andMycobacterium tuberculosis-Infected Mice(1998)141 cited
→ Antimycobacterial and cytotoxicity activity of synthetic and natural compounds(2007)139 cited
→ Towards a DNA vaccine against tuberculosis(1994)120 cited
→ Blockade of Endogenous Leukotrienes Exacerbates Pulmonary Histoplasmosis(2004)120 cited

→ Protection against tuberculosis by a single intranasal administration of DNA-hsp65 vaccine complexed with cationic liposomes(2008)

104 cited

A single mycobacterial protein (hsp 65) expressed by a transgenic antigen-presenting cell vaccinates mice against tuberculosis.(1994)

→ Single dose of a vaccine based on DNA encoding mycobacterial hsp65 protein plus TDM-loaded PLGA microspheres protects mice against a virulent strain of Mycobacterium tuberculosis(2003)95 cited

→ Immunotherapy with plasmid DNA encoding mycobacterial hsp65 in association with chemotherapy is a more rapid and efficient form of treatment for tuberculosis in mice(2004)92 cited